Showing results (151-160 of 2,880) with videos related to
Sort By:
Pageof 288
Expert Review of Cardiovascular Therapy|August 4, 2005
Ximelagatran for stroke prevention in atrial fibrillationChristopher J Boos, Gregory Y H LipCurrent Atherosclerosis Reports|May 22, 2018
Anticoagulation Resumption After Intracerebral HemorrhageYan-Guang Li, Gregory Y H LipThrombosis and Haemostasis|November 5, 2005
The potential role of platelet microparticles in atherosclerosisKiat T Tan, Gregory Y H LipCurrent Pharmaceutical Design|October 2, 2014
A brief history of 'lone' atrial fibrillation: from 'a peculiar pulse irregularity' to a modern public health concernTatjana S Potpara, Gregory Y H LipCurrent Pharmaceutical Design|September 28, 2007
From diabetes to metabolic syndrome: a viewpoint on an evolving conceptHoong Sern Lim, Gregory Y H LipThrombosis Research|October 4, 2005
Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: a systematic review and meta-analysisGregory Y H Lip, Steven J EdwardsCurrent Treatment Options in Cardiovascular Medicine|April 26, 2006
Platelet microparticles and platelet adhesion: therapeutic implications for the prevention and treatment of strokeKiat T Tan, Gregory Y H LipBest Practice & Research. Clinical Haematology|August 20, 2013
Novel oral anticoagulants in non-valvular atrial fibrillationTatjana S Potpara, Gregory Y H LipAnnals of Internal Medicine|April 5, 2021
In patients with AF and a bioprosthetic mitral valve, rivaroxaban was noninferior to warfarin for time to clinical eventsYing X Gue, Gregory Y H LipCurrent Pharmaceutical Design|February 1, 2012
Antiplatelet therapy in atherothrombotic cardiovascular diseases for primary and secondary prevention: a focus on old and new antiplatelet agentsBurak Pamukcu, Kurt Huber, Gregory Y H LipPageof 288